Drugs / Predisone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02042690 Comparator | Jul 2014 → Feb 2018 | acute lymphoblastic leukemia | Peking University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Predisone | “Vindesin 4mg/d，Predisone:1mg/kg, d1-7, every month during maintenance treatment for 2 years” NCT02042690 ↗ |